BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 115687)

  • 1. Characterization of a thyroliberin-degrading serum enzyme catalyzing the hydrolysis of thyroliberin at the pyroglutamyl-histidine bond.
    Bauer K; Nowak P
    Eur J Biochem; 1979 Sep; 99(2):239-46. PubMed ID: 115687
    [No Abstract]   [Full Text] [Related]  

  • 2. Specificity of a serum peptidase hydrolyzing thyroliberin at pyroglutamyl-histidine bone.
    Bauer K; Nowak P; Kleinkauf H
    Eur J Biochem; 1981 Aug; 118(1):173-6. PubMed ID: 6116600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineation of a particulate thyrotropin-releasing hormone-degrading enzyme in rat brain by the use of specific inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase.
    Friedman TC; Wilk S
    J Neurochem; 1986 Apr; 46(4):1231-9. PubMed ID: 2869108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide-specific peptidases: does brain contain a specific TRH-degrading enzyme?
    Wilk S
    Life Sci; 1986 Oct; 39(17):1487-92. PubMed ID: 3093794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the role of a pyroglutamyl peptidase, a post-proline cleaving enzyme and a post-proline dipeptidyl amino peptidase, each purified from the soluble fraction of guinea-pig brain, in the degradation of thyroliberin in vitro.
    Browne P; O'Cuinn G
    Eur J Biochem; 1983 Dec; 137(1-2):75-87. PubMed ID: 6140164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase on TRH degradation in rat serum.
    Friedman TC; Wilk S
    Biochem Biophys Res Commun; 1985 Oct; 132(2):787-94. PubMed ID: 2865955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catabolism of thyroliberin by rat adenohypophyseal tissue extract.
    Bauer K; Kleinkauf H
    Eur J Biochem; 1980 May; 106(1):107-17. PubMed ID: 6122566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial purification and characterization of a thyroliberin deamidase from guinea-pig brain.
    Donlon J; Hayes DJ; O'Cuinn G
    Biochem Soc Trans; 1980 Aug; 8(4):424. PubMed ID: 6778728
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibitors of TRH-degrading enzymes.
    Wilk S
    Ann N Y Acad Sci; 1989; 553():252-64. PubMed ID: 2566296
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of a thyrotropin-releasing hormone-degrading enzyme in GH3 cells: induction of pyroglutamyl peptidase I by 3,5,3'-triiodothyronine.
    Suen CS; Wilk S
    Endocrinology; 1987 Aug; 121(2):770-5. PubMed ID: 2885183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyroglutamyl peptidase: an overview of the three known enzymatic forms.
    Cummins PM; O'Connor B
    Biochim Biophys Acta; 1998 Dec; 1429(1):1-17. PubMed ID: 9920379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyroglutamyl diazomethyl ketone: potent inhibitor of mammalian pyroglutamyl peptide hydrolase.
    Wilk S; Friedman TC; Kline TB
    Biochem Biophys Res Commun; 1985 Jul; 130(2):662-8. PubMed ID: 2862865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyroglutamyl peptidase II inhibition enhances the analeptic effect of thyrotropin-releasing hormone in the rat medial septum.
    Lazcano I; Uribe RM; Martínez-Chávez E; Vargas MA; Matziari M; Joseph-Bravo P; Charli JL
    J Pharmacol Exp Ther; 2012 Jul; 342(1):222-31. PubMed ID: 22532627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of the phosphinic analogue of thyrotropin releasing hormone.
    Matziari M; Bauer K; Dive V; Yiotakis A
    J Org Chem; 2008 Nov; 73(21):8591-3. PubMed ID: 18826326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active site studies on a narrow-specificity thyroliberin-hydrolysing pyroglutamate aminopeptidase purified from synaptosomal membrane of guinea-pig brain.
    O'Connor B; O'Cuinn G
    J Neurochem; 1987 Mar; 48(3):676-80. PubMed ID: 2879887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of a particulate thyrotropin-releasing hormone-degrading pyroglutamate aminopeptidase activity in rat liver.
    Scharfmann R; Morgat JL; Aratan-Spire S
    Neuroendocrinology; 1989 Apr; 49(4):442-8. PubMed ID: 2566131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of the thyrotropin-releasing hormone (TRH)-degrading serum enzyme and its identification as a product of liver origin.
    Schmitmeier S; Thole H; Bader A; Bauer K
    Eur J Biochem; 2002 Feb; 269(4):1278-86. PubMed ID: 11856362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of a narrow-specificity thyroliberin hydrolyzing pyroglutamate aminopeptidase in synaptosomal membranes of guinea-pig brain.
    O'Connor B; O'Cuinn G
    Eur J Biochem; 1984 Oct; 144(2):271-8. PubMed ID: 6149121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible role of neuropeptide degrading enzymes on thyroliberin secretion in fetal hypothalamic cultures grown in serum free medium.
    Faivre-Bauman A; Loudes C; Barret A; Tixier-Vidal A; Bauer K
    Neuropeptides; 1986; 7(2):125-38. PubMed ID: 2871517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of the thyrotropin-releasing hormone-degrading ectoenzyme. similarities and differences with other members of the M1 family of aminopeptidases and thermolysin.
    Papadopoulos T; Kelly JA; Bauer K
    Biochemistry; 2001 Aug; 40(31):9347-55. PubMed ID: 11478903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.